Refreshing results…
GD3 ganglioside is a promising therapeutic target for glioma patients.
Download from doi.orgLRP1B deletion is associated with poor outcome for glioblastoma patients
Download from www.researchgate.netPrimary neurolymphomatosis diagnosis and treatment: A retrospective study
Download from www.researchgate.netMissing publications? Search for publications with a matching author name.